Opendata, web and dolomites


The first portable monitoring medical device providing accurate prognosis for patients with circulatory failure

Total Cost €


EC-Contrib. €






 Oximonitor project word cloud

Explore the words cloud of the Oximonitor project. It provides you a very rough idea of what is the project "Oximonitor" about.

financial    clinical    platform    skin    interpretation    site    individuals    effectiveness    cells    dashboard    millions    optical    monitors    bedside    2023    societal    respiratory    generating    roi    manner    creates    sublingually    extracorporeal    data    machine    predict    ip    report    first    heart    sepsis    survivors    acute    computing    company    billion    health    profit    dead    life    accurately    start    costing    decision    recover    validated    medical    collects    mlab    proof    39    monitoring    point    norwegian    patented       12    symptom    34    75    invasive    likewise    cumulative    ecmo    oxygenation    2017    quantifying    worldwide    count    22    neonatal    asphyxia    exemplified    cloud    body    function    viability    circulatory    surface    inability    collecting    17    software    expand    microcirculatory    staff    enormous    care    patient    learning    incorporates    cardiac    sufficient    oximonitor    membrane    hardware    400    2022    fingerprint    specialists    clab    conjunctiva    market    clinically    o2    poc    treatment    sent    cagr    patients    back    35    odi   

Project "Oximonitor" data sheet

The following table provides information about the project.


Organization address
city: OSLO
postcode: 349
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2019-06-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ODI MEDICAL AS NO (OSLO) coordinator 50˙000.00


 Project objective

Microcirculatory failure (the inability to deliver sufficient O2 to the cells of the body), is a symptom from several health conditions affecting millions of individuals worldwide (e.g. heart failure, neonatal asphyxia or sepsis). The societal and financial impact of these conditions is enormous, as exemplified by patients in need of cardiac and respiratory support (such as extracorporeal membrane oxygenation life support or ECMO), with only 17% of survivors, while costing up to 1.35 M€ for a 1-year treatment. Specialists cannot predict if these patients are clinically dead or can recover because available medical devices do not allow to monitoring patient´s microcirculatory function. To solve this, at ODI Medical (a Norwegian start-up company) we have developed OXIMONITOR, the first-ever proof-of-concept validated, patented and non-invasive point of care (POC) integrated platform used bedside that accurately monitors microcirculatory function by quantifying O2 delivery and allows to assess the effectiveness of the patient´s treatment of choice, all in a user-friendly manner. OXIMONITOR incorporates: (1) The mLab hardware which creates an “optical fingerprint” of the patient’s circulatory function by collecting data from the surface of the patient’s skin, the conjunctiva or even sublingually. (2) The cLab; a Cloud computing software based on machine learning technology that collects and analyses the data generating the patient´s interpretation report, which is sent back to the clinical site through a user-friendly dashboard for decision-making. The market of cardiac monitoring (our first clinical application) will reach €22 billion by 2022 at a CAGR of 3.9% (2017-2022). With OXIMONITOR we will contribute to the viability of our company, generating a cumulative profit of 34.39 M€ (ROI of 12.75) and growing our staff count 400% by 2023. Likewise, the IP generated by this project will allow us to expand the number of clinical applications using our platform.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OXIMONITOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OXIMONITOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

GREEN WHS (2019)


Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

SQP (2019)

Opening new markets for Single Quantum Photodetectors

Read More